Form 4: Oscar Health Co-Founder and Vice Chairman, Joshua Kushner, Increases Stake Through Multiple Share Purchases
SEC Form 4 Filing
Joshua Kushner, Co-Founder and Vice Chairman of Oscar Health, has increased his indirect holdings through multiple purchases of Class A Common Stock.
Summary
- Joshua Kushner, Co-Founder and Vice Chairman of Oscar Health, indirectly acquired shares of Class A Common Stock through Thrive Capital Partners VII Growth, L.P. and Claremount VII Associates, L.P.
- On November 20, 2024, a total of 88,395 shares were purchased at a weighted average price of $16.9659 per share.
- On November 21, 2024, an additional 100,000 shares were purchased at a weighted average price of $16.8598 per share.
- These purchases increased Mr. Kushner's total indirect holdings to 6,343,617 shares.
- The shares were purchased in multiple transactions at prices ranging from $16.60 to $17.00, inclusive, and in accordance with Rule 10b-18.
Sentiment
Score: 6
Explanation: The document indicates insider buying, which is generally a positive sign, but it's not a major event and doesn't provide a comprehensive view of the company's health. The sentiment is therefore moderately positive.
Positives
- The purchases indicate a potential positive sentiment from a key insider regarding the company's future prospects.
- The increased stake by a co-founder and Vice Chairman could be seen as a vote of confidence in the company.
Risks
- The document does not provide any information about the company's overall performance or financial health.
- The purchases are made indirectly through investment vehicles, which may not fully reflect Mr. Kushner's personal investment decisions.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. It does not provide any specific insights into the broader healthcare industry or competitive landscape.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly listed companies, and this filing is consistent with standard reporting requirements.
- The share purchases are relatively small compared to the overall market capitalization of Oscar Health, and are not unusual for a company of this size.
- Comparable companies would also have similar filings when insiders trade their company's stock.
Stakeholder Impact
- The increased stake by a key insider could positively influence investor confidence.
- The purchases may have a minor positive impact on the share price.
Key Dates
| Date | Description |
|---|---|
| 11/20/2024 | Date of the first reported share purchase transaction. |
| 11/21/2024 | Date of the second reported share purchase transaction. |
| 11/22/2024 | Date of the signature on the SEC Form 4 filing. |
Keywords
Oscar Health, Joshua Kushner, Class A Common Stock, Insider Trading, Share Purchase, Thrive Capital, Claremount VII, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.